Dose escalation to 84 Gy with concurrent chemotherapy in stage III NSCLC appears excessively toxic: Results from a prematurely terminated randomized phase II trial
Hallqvist, Andreas, Bergström, Stefan, Björkestrand, Hedvig, Svärd, Anna-Maja, Ekman, Simon, Lundin, Erik, Holmberg, Erik, Johansson, Mikael, Friesland, Signe, Nyman, Jan
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2018)
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2018)
Get full text
Journal Article
The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial)
van Diessen, Judi, De Ruysscher, Dirk, Sonke, Jan-Jakob, Damen, Eugène, Sikorska, Karolina, Reymen, Bart, van Elmpt, Wouter, Westman, Gunnar, Fredberg Persson, Gitte, Dieleman, Edith, Bjorkestrand, Hedvig, Faivre-Finn, Corinne, Belderbos, José
Published in Radiotherapy and oncology (01.02.2019)
Published in Radiotherapy and oncology (01.02.2019)
Get full text
Journal Article